Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|July 14, 2016
Ribosomal S6 kinase (RSK) modulators: a patent reviewKatarzyna A Ludwik, Deborah A Lannigan
Molecular & Cellular Oncology|November 25, 2020
RSK2 and ERα comrades-in-arms in homeostasis and transformationKatarzyna A Ludwik, Deborah A Lannigan
Methods (San Diego, Calif.)|February 12, 2019
Genome-wide analysis of RNA and protein localization and local translation in mESC-derived neuronsKatarzyna A Ludwik, Nicolai von Kuegelgen, Marina Chekulaeva
STAR Protocols|July 23, 2023
ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCsKatarzyna A Ludwik, Narasimha Telugu, Sandra Schommer, et al.
Cancer Research|January 21, 2018
ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer TumorigenesisKatarzyna A Ludwik, Oliver G McDonald, David R Brenin, et al.
Stem Cell Research|April 26, 2025
Generation of hiPSC lines with fusion tagged thyroid hormone receptor α isoforms to study isoform-specific actions of TRα1 and TRα2Nina Härting, Katarzyna A Ludwik, Regina Jahn, et al.
STAR Protocols|January 25, 2021
FACS protocol for direct comparison of cell populations isolated from miceKatarzyna A Ludwik, Zachary M Sandusky, Eric B Wright, et al.
Stem Cell Research|December 15, 2023
Generation of THRB-GS(E125G_G126S) and THRB-KO human iPSC lines to study noncanonical thyroid hormone signallingKatarzyna A Ludwik, Regina Jahn, Ann-Kathrin Schörding, et al.
Stem Cell Research|March 22, 2025
Correction of the Allan-Herndon-Dudley syndrome-causing SLC16A2 mutation G401R in a patient derived hiPSC lineKatarzyna A Ludwik, Robert Opitz, Sabine Jyrch, et al.
Stem Cell Research|May 1, 2025
Generation of two human induced pluripotent stem cell lines from Allan-Herndon-Dudley syndrome (AHDS) patients with SLC16A2:G401R or SLC16A2: H192R mutationKatarzyna A Ludwik, Judit Küchler, David Sebinger, et al.
Pageof 2